Concepedia

Rose Snipes

RS

6

Publications

392

Citations

6

H-Index

2010

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

UCB Pharma (United Kingdom)

University Hospital of Wales

Medical University of Lodz

UCB Pharma (Germany)

Rose Snipes is an author at GlaxoSmithKline (United States) specializing in medicine, diabetes, and cardiovascular disease.

Top concepts

Publications per year

2010–2020

6

Publications

6

Prevalence of Severe (500 to 2,000 mg/dl) Hypertriglyceridemia in United States Adults

Jennifer Christian, Nancy Bourgeois, Rose Snipes et al. · The American Journal of Cardiology · 2011 · 150 citations · Full text

, , +11

Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

Tadeusz Robak, Maciej Kaźmierczak, Isidro Jarque et al. · Blood Advances · 2020 · 107 citations · Full text

, , +23

Determining Triglyceride Reductions Needed for Clinical Impact in Severe Hypertriglyceridemia

Jennifer Christian, Bhakti Arondekar, Erin Buysman et al. · The American Journal of Medicine · 2013 · 74 citations

, , +11

Effect of Darapladib Treatment on Endarterectomy Carotid Plaque Lipoprotein-Associated Phospholipase A2 Activity: A Randomized, Controlled Trial

Joel L. Johnson, Yi Shi, Rose Snipes et al. · PLoS ONE · 2014 · 27 citations · Full text

Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients

Harold Bays, Kevin C. Maki, James M. McKenney et al. · Current Medical Research and Opinion · 2010 · 22 citations

Rows per page

1–5 of 6